Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of nitroxoline against Escherichia coli urine isolates from outpatient departments in Germany.

× No keyword cloud information.

10 in total

1. Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010.

Authors: Sofia Maraki; Elpis Mantadakis; Lambros Michailidis; George Samonis
Journal: J Microbiol Immunol Infect Date: 2012-07-12 Impact factor: 4.399

2. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.

Authors: Gunnar Kahlmeter; Hanna Odén Poulsen
Journal: Int J Antimicrob Agents Date: 2011-11-03 Impact factor: 5.283

3. Rapid and selective inhibition of RNA synthesis in yeast by 8-hydroxyquinoline.

Authors: R S Fraser; J Creanor
Journal: Eur J Biochem Date: 1974-07-01

4. [Inhibition of bacterial adherence by nitroxoline on cellular adhesion and on urinary catheter surfaces].

Authors: P Bourlioux; H Botto; D Karam; A Amgar; M Camey
Journal: Pathol Biol (Paris) Date: 1989-05

5. [Inhibition of bacterial adhesion of uropathogenic Escherichia coli strains by the urine of patients treated with nitroxoline].

Authors: D Karam; A Amgar; P Bourlioux
Journal: Pathol Biol (Paris) Date: 1988-05

6. Antibacterial activity of nitroxoline and sulphamethizole alone and in combination in urinary tract infections.

Authors: M R Jacobs; R G Robinson; H J Koornhof
Journal: S Afr Med J Date: 1978-12-02

7. Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System.

Authors: Seung-Ju Lee; Dong Sup Lee; Hyun Sop Choe; Bong Suk Shim; Chul Sung Kim; Min Eui Kim; Yong-Hyun Cho
Journal: J Infect Chemother Date: 2010-12-08 Impact factor: 2.211

8. Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers.

Authors: Florian M E Wagenlehner; Fabian Münch; Adrian Pilatz; Birte Bärmann; Wolfgang Weidner; Christine M Wagenlehner; Marion Straubinger; Holger Blenk; Wolfgang Pfister; Michael Kresken; Kurt G Naber
Journal: Antimicrob Agents Chemother Date: 2013-11-11 Impact factor: 5.191

Review 9. [Present status of nitroxoline].

Authors: E Bergogne-Berezin; G Berthelot; C Muller-Serieys
Journal: Pathol Biol (Paris) Date: 1987-06

10. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.

Authors: Michael Kresken; Yvonne Pfeifer; Dieter Hafner; Rebecca Wresch; Barbara Körber-Irrgang
Journal: Int J Antimicrob Agents Date: 2014-07-16 Impact factor: 5.283

10 in total

6 in total

1. In Vitro Activity of Nitroxoline in Antifungal-Resistant Candida Species Isolated from the Urinary Tract.

Authors: Frieder Fuchs; Alexander Maximilian Aldejohann; Ada Marie Hoffmann; Grit Walther; Oliver Kurzai; Axel G Hamprecht
Journal: Antimicrob Agents Chemother Date: 2022-05-11 Impact factor: 5.938

2. In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis.

Authors: Ada Marie Hoffmann; Martina Wolke; Jan Rybniker; Georg Plum; Frieder Fuchs
Journal: Front Pharmacol Date: 2022-05-26 Impact factor: 5.988

6. Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study.

Authors: Ulrich Dobrindt; Haleluya T Wami; Torsten Schmidt-Wieland; Daniela Bertsch; Klaus Oberdorfer; Herbert Hof
Journal: Antibiotics (Basel) Date: 2021-05-28